KREATECH Biotechnology B.V. Announces REPLI-g(R) Whole Genome Amplification Technology Supply Agreement With QIAGEN For arrayCGH Labeling Kits

AMSTERDAM, June 8 /PRNewswire/ -- Kreatech Biotechnology BV ( and QIAGEN GmbH a wholly-owned subsidiary of QIAGEN ( have signed a supply agreement pursuant to which Kreatech will market QIAGEN's REPLI-g® Whole Genome Amplification (WGA) Kits in combination with their proprietary Universal Linkage System (ULS(TM)) for the life science research marketplace. The coupling of the ULS(TM) technology with REPLI-g® will enable Kreatech to offer researchers the advantages of direct labeling of REPLI-g® amplified genomic DNA with ULS(TM).

Back to news